NOW APPROVED FOR gMG

Announcing

ZILBRYSQ

The first FDA-approved self-administered treatment for adults
with anti-AChR antibody-positive GENERALIZED MYASTHENIA GRAVIS (gMG)

AChR=acetylcholine receptor.

Sign up here to receive email updates
and information about ZILBRYSQ.

All fields are required

I am 18 years of age or older.

By providing your information on this webpage, you acknowledge you are a U.S. resident and give UCB and its business partners permission to send you information or contact you and/or your healthcare provider regarding your disease, as well as information on other related treatments, products, and services, and for marketing and informational purposes by email or postal mail. You understand that UCB or its business partners will not sell your name, address, email address, or any other information to another party for their own marketing use.

At any time, you may unsubscribe and remove yourself from the mailing list. Please review the Privacy Policy.

Complete Terms of Use.